These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37767187)

  • 61. PAQR3 depletion accelerates diabetic wound healing by promoting angiogenesis through inhibiting STUB1-mediated PPARγ degradation.
    Qiu J; Shu C; Li X; Zhang WC
    Lab Invest; 2022 Oct; 102(10):1121-1131. PubMed ID: 35710596
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A review on the role of miR-671 in human disorders.
    Ghafouri-Fard S; Askari A; Hussen BM; Rasul MF; Hatamian S; Taheri M; Kiani A
    Front Mol Biosci; 2022; 9():1077968. PubMed ID: 36545507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.
    Shen J; Liang C; Su X; Wang Q; Ke Y; Fang J; Zhang D; Duan S
    Biomark Res; 2022 Sep; 10(1):72. PubMed ID: 36175921
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.
    Dong Z; Yang L; Lu J; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2022 Aug; 39(4):661-677. PubMed ID: 35616822
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
    Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
    Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
    Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
    Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway.
    Zhang F; Cao H
    Int J Oncol; 2019 Feb; 54(2):689-701. PubMed ID: 30535502
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-33a-5p suppresses esophageal squamous cell carcinoma progression via regulation of lncRNA DANCR and ZEB1.
    Zhang C; Wang L; Yang J; Fu Y; Li H; Xie L; Cui Y
    Eur J Pharmacol; 2019 Oct; 861():172590. PubMed ID: 31401160
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X; Teng F
    Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
    Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
    Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells.
    Tang W; Jia P; Zuo L; Zhao J
    Cell Cycle; 2022 Aug; 21(16):1697-1709. PubMed ID: 35485293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Prominent Role of miR-942 in Carcinogenesis of Tumors.
    Yadegar N; Dadashi Z; Shams K; Mohammadi M; Abyar M; Rafat M
    Adv Biomed Res; 2022; 11():63. PubMed ID: 36133499
    [TBL] [Abstract][Full Text] [Related]  

  • 76. miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2.
    Wu B; Liu G; Jin Y; Yang T; Zhang D; Ding L; Zhou F; Pan Y; Wei Y
    Front Oncol; 2020; 10():108. PubMed ID: 32175269
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus.
    Xu D; Wang Z; Zhang Y; Jiang W; Pan Y; Song BL; Chen Y
    Nat Commun; 2015 Aug; 6():8100. PubMed ID: 26311497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.
    Ren C; Chen H; Han C; Fu D; Zhou L; Jin G; Wang F; Wang D; Chen Y; Ma L; Zheng X; Han D
    Oncotarget; 2016 Mar; 7(13):15840-53. PubMed ID: 26895105
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MiR-183-5p Promotes Tumor Progression of Osteosarcoma and Predicts Poor Prognosis in Patients.
    Jin L; Luo Y; Zhao YC; Tao H
    Cancer Manag Res; 2021; 13():805-814. PubMed ID: 33536788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.